ClinicalTrials.Veeva

Menu

Frequency of Circulating Tumour Cells in Stage II and Stage III Colon Cancer Patients

A

Alberta Health services

Status

Completed

Conditions

Colon Cancer

Treatments

Procedure: Cell Search Assay

Study type

Observational

Funder types

Other

Identifiers

NCT00351572
GI-5-0055

Details and patient eligibility

About

This study will determine whether a new diagnostic test called the Cell Search Assay can detect circulating colon cancer cells in patients who have had surgery for colon cancer and had visible cancer removed. Other parts of the study will look at whether the presence of the circulating tumor cells in blood predicts whether a patient will have their colon cancer return.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • stage II or III colon cancer

Exclusion criteria

  • none

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems